Clinical Trials Browser

Phase 1/2 × Head and Neck Carcinoma × Head & Neck × Clear all

NCT02718820 2024-01-09

Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer

Phase 1/2 Completed

22 enrolled 10 charts

Head and Neck Carcinoma

NCT03745690 2022-03-17

Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer

Phase 1/2 Withdrawn

Head and Neck Carcinoma